W. Ensminger

发表

NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

Yun Yen, Steven A Curley, Edgar Ben-Josef, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.

L. Junck, W. Ensminger, W. Chandler, 1984, Journal of neurosurgery.

Targeting Hepatic Cancer Cells with PEGylated Dendrimers Displaying N‐Acetylgalactosamine and SP94 Peptide Ligands

Scott H. Medina, W. Ensminger, M. ElSayed, 2013, Advanced healthcare materials.

Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.

S. Dakhil, W. Ensminger, G. Kindt, 1981, Cancer treatment reports.

Dosimetric analysis of radiation-induced gastric bleeding.

R. T. Ten Haken, L. Dawson, T. Lawrence, 2012, International journal of radiation oncology, biology, physics.

Response of human HT-29 colorectal tumor cells to extended exposure to bromodeoxyuridine

M. Hafner, P. Stetson, W. Ensminger, 2004, Cancer Chemotherapy and Pharmacology.

Floxuridine-associated sclerosing cholangitis. A dog model.

J. Knol, W. Ensminger, D. Prieskorn, 1989, Investigative radiology.

Effects of Dexamethasone or Celecoxib on Biliary Toxicity after Hepatic Arterial Infusion of 5-Fluorodeoxyuridine in a Canine Model

David A. Williams, J. Knol, J. Maybaum, 2004, Cancer Research.

Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings.

I. Francis, W. Ensminger, C. Marn, 1993, Radiology.

A Phase 1 study of high doses of aminopterin with leucovorin rescue in patients with advanced metastatic tumors.

W. Ensminger, L. M. Glodé, E. Frei, 1979, Cancer research.

RESPONSE FORCE AS A FUNCTION OF AMOUNT OF REINFORCEMENT.

J. M. Notterman, W. Ensminger, V. Dilollo, 1965, Journal of experimental psychology.

Hepatic arterial chemotherapy for primary and metastatic liver cancers

W. Ensminger, 2004, Cancer Chemotherapy and Pharmacology.

Effects of hepatic arterial yttrium 90 glass microspheres in dogs

J. Juni, W. Ensminger, S. Warber, 1988, Cancer.

Pharmacologic Studies of Hepatic Intra-Arterial Chemotherapy

W. Ensminger, J. Gyves, 1985 .

Degradable Starch Microspheres

W. Ensminger, 1984 .

Improved regional selectivity of hepatic arterial mitomycin by starch microspheres

J. Niederhuber, P. Stetson, W. Ensminger, 1983, Clinical pharmacology and therapeutics.

Regional chemotherapy of neoplastic diseases.

W. Ensminger, J. Gyves, 1983, Pharmacology & therapeutics.

N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers.

Scott H. Medina, W. Ensminger, M. El-Sayed, 2011, Biomaterials.

Regional chemotherapy.

W. Ensminger, 1993, Seminars in oncology.

Interaction between gemcitabine and mitomycin-C in vitro

T. Lawrence, Mary A Davis, W. Ensminger, 2000, Cancer Chemotherapy and Pharmacology.

A role for hepatic-directed chemotherapy in colorectal liver metastases.

W. Ensminger, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypervascular hepatic metastases: CT evaluation.

G. Glazer, I. Francis, W. Ensminger, 1987, Radiology.

Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.

E. Heath, D. Dang, S. Chun, 2008, Cancer research.

High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.

W. Ensminger, R. Wheeler, A. Lobuglio, 1985, Seminars in oncology.

Clinical pharmacology of hepatic arterial chemotherapy.

W. Ensminger, J. Gyves, 1983, Seminars in oncology.

Surgical considerations in the management of hepatic neoplasia.

J. Niederhuber, W. Ensminger, 1983, Seminars in oncology.

Dosimetric Analysis of Radiation-induced Gastric

L. Dawson, T. Lawrence, C. Pan, 2012 .

Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases

M. Schipper, T. Lawrence, D. Normolle, 2016, American journal of clinical oncology.

Intrahepatic arterial infusion of chemotherapy: pharmacologic principles.

W. Ensminger, 2002, Seminars in oncology.

Radiosensitization with carotid intra‐arterial bromodeoxyuridine ± 5‐fluorouracil biomodulation for malignant gliomas

H. Sandler, L. Junck, W. Ensminger, 1994, Neurology.

A Phase 1 Study of High Doses of Aminopterin with Leucovorin Rescue in Patients with Advanced Metastatic Tumors 1

W. Ensminger, L. M. Glodé, E. Frei, 2006 .

Totally implanted system for intravenous chemotherapy in patients with cancer.

S. Dakhil, J. Niederhuber, W. Ensminger, 1982, The American journal of medicine.

Hepatobiliary cancers, version 2.2014.

T. Pawlik, J. Vauthey, Y. Yen, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

The use of 3-D dose volume analysis to predict radiation hepatitis.

Morton B. Brown, R. T. Ten Haken, M. Kessler, 1993, International journal of radiation oncology, biology, physics.

Analysis of bromodeoxyuridine incorporation into DNA: comparison of gas chromatographic/mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methods.

J. Maybaum, P. Stetson, W. Ensminger, 1987, Analytical biochemistry.

Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Use of a totally implanted drug delivery system.

J. Thrall, J. Niederhuber, W. Ensminger, 1984, Radiology.

Totally implanted drug delivery system for hepatic arterial chemotherapy.

J. Thrall, S. Dakhil, J. Niederhuber, 1981, Cancer treatment reports.

Hepatobiliary cancers. Clinical practice guidelines in oncology.

T. Yeatman, C. Earle, M. Sinanan, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.

M. Kessler, J. Robertson, T. Lawrence, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved regional selectivity of hepatic arterial bcnu with degradable microspheres

S. Dakhil, W. Ensminger, R. Wheeler, 1982, Cancer.

A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.

D. Levin, W. Ensminger, G. Steele, 1978, Cancer research.

Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.

W. Ensminger, B. Shapiro, L. Cotton, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line.

W. Ensminger, D. Shewach, J. Ellero, 1992, Biochemical pharmacology.

Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT).

J. Thrall, J. Niederhuber, W. Ensminger, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Effect of irradiation on bromodeoxyuridine incorporation in human colon cancer xenografts.

T. Lawrence, Mary A Davis, M. Davis, 1996, International journal of radiation oncology, biology, physics.

Cellular DNA replication in infections with cytocidal RNA viruses.

W. Ensminger, I. Tamm, R. Hand, 1971, Virology.

The step in cellular DNA synthesis blocked by reovirus infection.

W. Ensminger, I. Tamm, Igor Tamm, 1969, Virology.

Local thrombolytic therapy for hepatic artery thrombosis following chemotherapy infusion catheter placement.

W. Ensminger, K. Cho, J. Andrews, 1985, Investigative radiology.

Treatment of central nervous system tumors with methotrexate.

D. Kufe, W. Ensminger, H. Abelson, 1981, Cancer treatment reports.

Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.

W. Ensminger, S. Baker, R. Wheeler, 1983, Medical and pediatric oncology.

Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy.

P. Roberson, R. T. Ten Haken, D. McShan, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor.

W. Ensminger, P. Mckeever, D. Prieskorn, 1991, Selective cancer therapeutics.

Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts.

T. Lawrence, W. Ensminger, Sheng-ping Li, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.

T. Lawrence, J. Maybaum, M. Davis, 1990, Radiation research.

Constant intraperitoneal 5‐fluorouracil infusion through a totally implanted system

M. Meyer, P. Stetson, W. Ensminger, 1984, Clinical pharmacology and therapeutics.

Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging.

T. Chenevert, G. Glazer, I. Francis, 1991, Radiology.

Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.

S. Gebarski, L. Junck, P. Stetson, 1988, Journal of neurosurgery.

Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.

S. Gebarski, M. Meyer, W. Ensminger, 1986, Cancer treatment reports.

A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy.

T. Lawrence, J. Knol, C. Pan, 2012, International journal of radiation oncology, biology, physics.

Regional chemotherapy of colorectal cancer metastatic to the liver

J. Thrall, J. Niederhuber, W. Ensminger, 1984, Cancer.

Ocular toxicity associated with high-dose carmustine.

D. Bienfang, H. Greenberg, D. Albert, 1982, Archives of ophthalmology.

High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia.

J. Thrall, W. Ensminger, R. Wheeler, 1982, Cancer treatment reports.

Thymidine 5'-O-pivaloate. A prodrug derivative of thymidine with potential applications in high-dose methotrexate therapy.

W. Ensminger, A. Rosowsky, 1979, Biochemical pharmacology.

Use of Implantable Pump Systems for Intraarterial, Intraventricular and Intratumoral Treatment of Malignant Brain Tumors

S. Gebarski, L. Junck, H. Greenberg, 1988, Annals of the New York Academy of Sciences.

A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin.

W. Ensminger, M. Israel, M. Garnick, 1979, Cancer research.

A phase I trial of intravenous bromodeoxyuridine and radiation therapy for pancreatic cancer.

J. Robertson, T. Lawrence, W. Ensminger, 1997, International journal of radiation oncology, biology, physics.

Combination chemo-radiation therapy for jaundice due to focal malignant obstruction of the major bile ducts.

J. Knol, A. Lichter, W. Ensminger, 1989, Selective cancer therapeutics.

The use of 3-D dose volume analysis to predict radiation hepatitis.

R. T. Ten Haken, M. Kessler, J. Robertson, 1993, International journal of radiation oncology, biology, physics.

Phase II study of hepatic arterial degradable starch microspheres and mitomycin.

W. Ensminger, I. Wollner, S. Walker-Andrews, 1986, Cancer drug delivery.

Stability of trimetrexate, a new non-classical antifolate, in infusion solutions.

W. Ensminger, U. Shukla, P. Stetson, 1991, Journal of chromatography.

Intra-arterial 5-bromo-2-deoxyuridine (BUR) radiosensitization with external beam radiation in rhesus monkeys: A toxicity study

S. Gebarski, A. Lichter, W. Ensminger, 1988, Journal of Neuro-Oncology.

Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain.

W. Ensminger, J. Taren, H. Greenberg, 1982, Journal of neurosurgery.

A totally implanted injection port system for blood sampling and chemotherapy administration.

J. Niederhuber, W. Ensminger, T. Dent, 1984, JAMA.

Hepatic toxicity resulting from cancer treatment.

M. Anscher, J. Robertson, L. F. Fajardo, 1995, International journal of radiation oncology, biology, physics.

Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model.

T. Lawrence, W. Ensminger, Z. Symon, 2001, International journal of radiation oncology, biology, physics.

The prevention of methotrexate toxicity by thymidine infusions in humans.

W. Ensminger, E. Frei, E. Frei, 1977, Cancer research.

Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.

Alnawaz Rehemtulla, Shengping Li, Theodore S Lawrence, 2003, Cancer research.

Inhibition of Synchronized Cellular Deoxyribonucleic Acid Synthesis During Newcastle Disease Virus, Mengovirus, or Reovirus Infection

W. Ensminger, I. Tamm, 1970, Journal of virology.

The step in cellular DNA synthesis blocked by Newcastle disease or mengovirus infection.

W. Ensminger, I. Tamm, Igor Tamm, 1970, Virology.

Intraarterial infusion chemotherapy for head and neck cancer using a totally implantable infusion pump.

J. Niederhuber, W. Ensminger, S. Baker, 1981, Head & neck surgery.

The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy

Brigham, W. Ensminger, J. Forman, 1980, Cancer.

Thymidine rescue of high-dose methotrexate in humans.

S. Howell, W. Ensminger, A. Krishan, 1978, Cancer research.

Incorporation of 5-bromo-2'-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion.

J. Robertson, T. Lawrence, J. Knol, 1995, Cancer research.

Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.

T. Lawrence, J. Maybaum, Mary A Davis, 1992, International journal of radiation oncology, biology, physics.

Thymidine arrest and synchrony of cellular growth in vivo.

D. Kufe, W. Ensminger, E. Frei, 1980, Cancer treatment reports.

Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.

J. Kirkwood, W. Ensminger, E. Frei, 1980, Cancer research.

Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.

W. Ensminger, M. Levi, David E. Smith, 2004, Biopharmaceutics & drug disposition.

Regional pharmacokinetics of amifostine in anesthetized dogs: role of the liver, gastrointestinal tract, lungs, and kidneys.

L. Shaw, J. Knol, S. Lunte, 2002, Drug metabolism and disposition: the biological fate of chemicals.

Cellular DNA and protein synthesis in reovirus-infected L cells.

W. Ensminger, I. Tamm, 1969, Virology.

Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy

J. Thrall, J. Niederhuber, W. Ensminger, 1982 .

Pharmacologic studies on the dibutyl and γ-monobutyl esters of methotrexate in the rhesus monkey

E. Modest, D. Kufe, W. Ensminger, 1982, Cancer Chemotherapy and Pharmacology.

Methotrexate analogues. 11. Unambiguous chemical synthesis and in vitro biological evaluation of alpha- and gamma-monoesters as potential prodrugs.

H. Lazarus, W. Ensminger, G. P. Beardsley, 1978, Journal of medicinal chemistry.

The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.

T. Lawrence, T. Lawrence, J. Maybaum, 1990, International journal of radiation oncology, biology, physics.

Hepatic arterial streptozocin: a clinical pharmacologic study in patients with liver tumors.

M. Meyer, P. Stetson, W. Ensminger, 1983, Cancer drug delivery.

Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.

T. Lawrence, J. Maybaum, Mary A Davis, 1991, Cancer research.

A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.

M. Kessler, C. Mcginn, J. Robertson, 1997, International journal of radiation oncology, biology, physics.

CONFORMAL RADIATION THERAPY FOR PATIENTS WITH PRIMARY HEPATOBILIARY CANCERS OR COLORECTAL LIVER METASTASES

M. Kessler, C. Mcginn, J. Robertson, 1997 .

Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.

T. Lawrence, J. Maybaum, M. Davis, 1994, Cancer research.

Clinical pharmacology of hepatic arterial infusions of 5-bromo-2'-deoxyuridine.

J. Wagner, T. Lawrence, J. Knol, 1994, Cancer research.

The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.

T. Lawrence, J. Maybaum, Mary A Davis, 1992, Cancer research.

Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.

J. Knol, D. Normolle, W. Ensminger, 1991, Journal of the National Cancer Institute.

Pharmacodynamics of 5-iodo-2'-deoxyuridine in VX2 tumor-bearing rabbits.

W. Ensminger, P. Stetson, Z. M. Yang, 1989, Journal of the National Cancer Institute.

Simultaneous determination of thymine and 5-bromouracil in DNA hydrolysates using gas chromatography-mass spectrometry with selected-ion monitoring.

J. Maybaum, P. Stetson, W. Ensminger, 1986, Journal of chromatography.

High-performance liquid chromatographic method for the determination of bromodeoxyuridine and its major metabolite, bromouracil, in biological fluids.

P. Stetson, W. Ensminger, U. Shukla, 1985, Journal of chromatography.

Gas-forming intrahepatic abscess: A possible complication of arterial infusion chemotherapy

Edward H. Smith, C. D'Orsi, W. Ensminger, 1979, Gastrointestinal Radiology.

Intra-arterial radionuclide infusion: a new technique to assess chemotherapy perfusion patterns.

C. D'Orsi, D. Levin, W. Ensminger, 1978, Cancer treatment reports.

A dog model using an implanted system for protracted hepatic arterial chemotherapy.

J. Niederhuber, P. Stetson, J. Juni, 1986, The Journal of surgical research.

Atlas of hepatic arterial perfusion scintigraphy.

J. Thrall, J. Juni, W. Ensminger, 1985, Clinical nuclear medicine.

Thrombosis and streptokinase lysis during hepatic intraarterial chemotherapy: the value of perfusion scintigraphy.

J. Juni, W. Ensminger, H. Ziessman, 1985, AJR. American journal of roentgenology.

Management, Complications, and Evaluation of Intra-arterial Infusions

W. Ensminger, 1984 .

Stability and function of mengovirus RNA in cell-free protein synthesis.

W. Ensminger, E. Henshaw, 1973, Biochemical and biophysical research communications.

BCNU solubility and toxicity in the treatment of malignant astrocytomas.

W D Ensminger, P. Stetson, W. Ensminger, 1984, Journal of neurosurgery.

Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging.

F. Bookstein, L. Quint, A. Aisen, 1988, Radiology.

Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.

S. Gebarski, L. Junck, P. Stetson, 1990, International Journal of Radiation Oncology, Biology, Physics.

Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy.

J. Thrall, J. Niederhuber, W. Ensminger, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

R. T. Ten Haken, L. Dawson, C. Mcginn, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.

M. Kessler, J. Robertson, T. Lawrence, 1997, International journal of radiation oncology, biology, physics.

The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.

M. Kessler, J. Robertson, T. Lawrence, 1995, International journal of radiation oncology, biology, physics.

Methotrexate-Carboxypeptidase G1: A Selective Approach to CNS Neoplasia

W. Ensminger, H. Abelson, A. Rosowsky, 1979 .

Cytokinetic evaluation of the four‐drug combination of bleomycin, vincristine, mitomycin c, and methotrexate (BOMM) in cultured burkitt'S lymphoma cells and human bone marrow

T. O'Toole, D. Clauw, W. Ensminger, 1982, Cancer.

Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model.

R. T. Ten Haken, C. Mcginn, T. Lawrence, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.

R. T. Ten Haken, L. Dawson, T. Lawrence, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.

R K Ten Haken, W D Ensminger, T S Lawrence, 1991, International journal of radiation oncology, biology, physics.

Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma.

W. Ensminger, U. Shukla, P. Stetson, 1985, Journal of chromatography.

5-Bromo-2'-deoxyuridine incorporation into DNA in hepatic VX2 tumor-bearing rabbits.

J. Wagner, J. Knol, P. Stetson, 1989, The Journal of surgical research.

Hepatic arterial BCNU: a pilot clinical-pharmacologic study in patients with liver tumors.

W. Ensminger, E. Egan, S. Come, 1978, Cancer treatment reports.

Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bromodeoxyuridine infusion in dogs.

P. Stetson, J. Juni, W. Ensminger, 1987, Cancer research.

Radionuclide angiography to predict patient response to hepatic artery chemotherapy.

C. D'Orsi, G. Steele, D. Levin, 1980, Cancer treatment reports.

Immunotherapy for cancer by direct gene transfer into tumors.

E. Nabel, A. Chang, B. Fox, 1994, Human gene therapy.

Phase I study of hepatic arterial degradable starch microspheres and mitomycin.

P. Stetson, W. Ensminger, J. Gyves, 1985, Cancer research.

Totally implanted venous and arterial access system to replace external catheters in cancer treatment.

J. Niederhuber, W. Ensminger, M. Liepman, 1982, Surgery.

Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy

David M. Williams, W. Ensminger, B. Shapiro, 1989, CardioVascular and Interventional Radiology.

The utility of SPECT for 99mTc-MAA hepatic arterial perfusion scintigraphy.

R. Wahl, J. Thrall, J. Juni, 1985, AJR. American journal of roentgenology.

Ambulatory pump infusion devices for hepatic artery infusion.

W. Ensminger, J. Lokich, 1983, Seminars in oncology.

Pharmacokinetics of Hepatic Arterial Chemotherapy

W. Ensminger, J. Gyves, 1986 .

Perfusion scintigraphy (Tc-99m MAA) during surgery for placement of chemotherapy catheter in hepatic artery: concise communication.

J. Thrall, J. Niederhuber, W. Ensminger, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Implanted system for intraventricular drug infusion in central nervous system tumors.

H. Greenberg, S. Dakhil, J. Niederhuber, 1981, Cancer treatment reports.

Experience with subcutaneous infusion ports in three hundred patients.

J. Niederhuber, W. Ensminger, J. Roberts, 1988, Surgery, gynecology & obstetrics.

Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.

W. Ensminger, H. Abelson, A. Rosowsky, 1978, Cancer treatment reports.

Hepatic falciform artery: anatomy, angiographic appearance, and clinical significance.

W. Ensminger, D. Williams, K. Cho, 1985, Radiology.

Long-term central venous access with a peripherally placed subcutaneous infusion port: initial results.

W. Ensminger, J. Andrews, S. Walker-Andrews, 1990, Radiology.

New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas.

W. Ensminger, W. Chandler, G. Kindt, 1982, Neurosurgery.

Steady-State NonlinearPharmacokineticsof 5-FluorouracilduringHepatic Arterialand IntravenousInfusionsin CancerPatients 1

J. Wagner, P. Stetson, W. Ensminger, 2006 .

Steady-StateNonlinearPharmacokinetics of 5-Fluorouracil duringHepatic Arterialand Intravenous Infusionsin CancerPatients1

J. Wagner, P. Stetson, W. Ensminger, 1986 .

Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.

W D Ensminger, J. Wagner, P. Stetson, 1986, Cancer research.

Escalated F ocal L iver R adiation a nd C oncurrent Hepatic A rtery F luorodeoxyuridi ne f or U nresectable Intrahepatic M alignancies

L. Dawson, C. Mcginn, T. Lawrence, 2000 .

Radiotherapy for pancreatic neuroendocrine tumors.

K. Griffith, T. Lawrence, J. Contessa, 2009, International journal of radiation oncology, biology, physics.

Hepatobiliary Cancers Clinical Practice Guidelines in OncologyTM

S. Curley, A. Benson, J. Marrero, 2009 .

MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors.

L. Quint, G. Glazer, I. Francis, 1987, AJR. American journal of roentgenology.

Regional pharmacokinetics of 5-fluorouracil in dogs: role of the liver, gastrointestinal tract, and lungs.

J. Knol, W. Ensminger, D. Smith, 1998, Cancer research.

Random sampling by glitter drop method.

L. Junck, H. Greenberg, W. Ensminger, 1990, Life sciences.

Pelvic radiation therapy combined with hepatic artery chemotherapy for resected rectal carcinoma with liver metastases.

J. Robertson, T. Lawrence, W. Ensminger, 1996, International journal of radiation oncology, biology, physics.

Biochemical pharmacology in medical oncology.

G. Steele, W. Ensminger, M. Israel, 1981, Cancer treatment reports.

70 A phase trial of chemoembolization with mitomycin C following hepatic arterial fluorodeoxyuridine/leucovorin and whole liver radiotherapy for patients with intrahepatic malignancies

C. Mcginn, J. Robertson, T. Lawrence, 1997 .

Methotrexate analogues. 8. Synthesis and biological evaluation of bisamide derivatives as potential prodrugs.

H. Lazarus, W. Ensminger, A. Rosowsky, 1977, Journal of medicinal chemistry.

Teaching skills for accessing and interpreting information from systematic reviews/meta-analyses, practice guidelines, and the Internet

Fredric M. Wolf, Larry D. Gruppen, Judith G. Miller, 1997, AMIA.

Divergent patterns of incorporation of bromodeoxyuridine and iododeoxyuridine in human colorectal tumor cell lines.

J. Maybaum, W. Ensminger, E. Burton, 1991, Biochemical pharmacology.

Pharmacological advantages of adriamycin via intra-hepatic arterial infusion

W. Ensminger, M. Israel, M. Garnick, 1978 .

Determination of plasma trimetrexate levels using gas chromatography-mass spectrometry with selected-ion monitoring.

W. Ensminger, P. Stetson, 1986, Journal of chromatography.

Visualization of tumor vascularity in a rabbit VX2 carcinoma by Doppler flow mapping.

P. Carson, J. Rubin, W. Ensminger, 1987, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients1

T. Lawrence, Mary A Davis, M. Feng, 2014, Translational oncology.

Intra-arterial Therapy of Hepatic Metastases

W. Ensminger, 1984 .

The treatment of primary hepatobiliary cancers with external beam radiation therapy and intraarterial hepatic fluorodeoxyuridine

J. Robertson, T. Lawrence, W. Ensminger, 1992 .

Comparisonof Pharmacokineticsof 5-Fluorouraciland 5-Fluorouracil with ConcurrentThymidine Infusionsin a Phase I Trial1

J. Kirkwood, W. Ensminger, E. Frei, 1980 .

Phase I study of intraperitoneal (IP) 5 day continuous 5-FU infusion and bolus mitomycin

J. Niederhuber, W. Ensminger, J. Gyves, 1982 .

Dynamics of Bromodeoxyuridine Incorporation into DNA of Squamous Carcinoma Cells During Mid and Late Logarithmic Growth

J. Wagner, T. Carey, J. Maybaum, 1988, Pharmaceutical Research.

Radiosensitization with Carotid Arterial Infusion of Bromodeoxyuridine (BUdR) ± 5 Fluorouracil (5FU) Biomodulation with Focal External Beam Radiation (FEBT) for Malignant Gliomas

H. Sandler, S. Gebarski, L. Junck, 1991 .

Modulation of liver tumor blood flow with hepatic arterial epinephrine: a SPECT study.

J. Juni, W. Ensminger, S. Warber, 1989, Radiology.